Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma

被引：1
|
作者：
Song, Yuxuan [1 ]
Peng, Yun [1 ]
Qin, Caipeng [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Dept Urol, Beijing 100044, Peoples R China
来源：
WORLD JOURNAL OF UROLOGY | 2023年 / 41卷 / 08期
关键词：
CANCER;
D O I：
10.1007/s00345-023-04497-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2301 / 2302
页数：2
相关论文
共 50 条
  • [21] Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
    Ishihara, Hiroki
    Ishiyama, Yudai
    Nemoto, Yuki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    CLINICAL GENITOURINARY CANCER, 2022, 21 (01) : 136 - 145
  • [22] Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Chen, Siteng
    Zhang, Ning
    Wang, Tao
    Zhang, Encheng
    Wang, Xiang
    Zheng, Junhua
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [23] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Flippot, Ronan
    Escudier, Bernard
    Albiges, Laurence
    DRUGS, 2018, 78 (14) : 1443 - 1457
  • [24] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Ronan Flippot
    Bernard Escudier
    Laurence Albiges
    Drugs, 2018, 78 : 1443 - 1457
  • [25] Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
    Tripathi, Abhishek
    Lin, Edwin
    Agarwal, Neeraj
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [26] Immune Checkpoint Inhibitors as Novel Targets for Renal Cell Carcinoma Therapeutics
    Bailey, Alexandra
    McDermott, David F.
    CANCER JOURNAL, 2013, 19 (04): : 348 - 352
  • [27] Pulmonary Metastasectomy after Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Sakanoue, Ichiro
    Hamaji, Masatsugu
    Nakajima, Daisuke
    Date, Hiroshi
    THORACIC AND CARDIOVASCULAR SURGEON, 2025, 73 (01): : 86 - 89
  • [28] Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors
    Hanif, Ahmad
    Pandey, Manu
    Khan, Sumera
    Attwood, Kristopher
    George, Saby
    ONCOIMMUNOLOGY, 2019, 8 (08):
  • [29] Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
    Makrakis, Dimitrios
    Talukder, Rafee
    Lin, Genevieve Ihsiu
    Diamantopoulos, Leonidas N.
    Dawsey, Scott
    Gupta, Shilpa
    Carril-Ajuria, Lucia
    Castellano, Daniel
    de Kouchkovsky, Ivan
    Koshkin, Vadim S.
    Park, Joseph J.
    Alva, Ajjai
    Bilen, Mehmet A.
    Stewart, Tyler F.
    Mckay, Rana R.
    Tripathi, Nishita
    Agarwal, Neeraj
    Vather-Wu, Naomi
    Zakharia, Yousef
    Morales-Barrera, Rafael
    Devitt, Michael E.
    Cortellini, Alessio
    Fulgenzi, Claudia Angela Maria
    Pinato, David J.
    Nelson, Ariel
    Hoimes, Christopher J.
    Gupta, Kavita
    Gartrell, Benjamin A.
    Sankin, Alex
    Tripathi, Abhishek
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Murgic, Jure
    Frobe, Ana
    Rodriguez-Vida, Alejo
    Drakaki, Alexandra
    Liu, Sandy
    Lu, Eric
    Kumar, Vivek
    Di Lorenzo, Giuseppe
    Joshi, Monika
    Isaacsson-Velho, Pedro
    Buznego, Lucia Alonso
    Duran, Ignacio
    Moses, Marcus
    Jang, Albert
    Barata, Pedro
    Sonpavde, Guru
    Yu, Evan Y.
    Montgomery, Robert Bruce
    CLINICAL GENITOURINARY CANCER, 2022, 20 (05) : E440 - E452
  • [30] Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors
    Rini, Brian I.
    ONCOLOGY-NEW YORK, 2022, 36 (08): : 511 - 515
12345